Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials
2018 ◽
Vol 174
(1)
◽
pp. 27-37
◽
2013 ◽
2022 ◽
2018 ◽
Vol 14
(10)
◽
pp. 600
◽
2019 ◽
Vol 18
◽
pp. 153473541986691
◽
2013 ◽
Vol 23
(1)
◽
pp. 21-30
◽
Keyword(s):
2018 ◽
Vol 27
(1)
◽
pp. 9-21
◽